Literature DB >> 4550324

Evaluation of nalbuphine for abuse potential.

D R Jasinski, P A Mansky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4550324     DOI: 10.1002/cpt197213178

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  16 in total

1.  COMPARATIVE HEMODYNAMIC EFFECTS OF NALBUPHINE AND MORPHINE IN PATIENTS WITH CORONARY ARTERY DISEASE.

Authors:  Alexander Romagnoli; Arthur S. Keats
Journal:  Cardiovasc Dis       Date:  1978-03

2.  Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

3.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers.

Authors:  A R Aitkenhead; E S Lin; K J Achola
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 5.  [Nalbuphine in pediatric anesthesia].

Authors:  A-M Schultz-Machata; K Becke; M Weiss
Journal:  Anaesthesist       Date:  2014-02       Impact factor: 1.041

6.  Human pharmacology of narcotic antagonists.

Authors:  D R Jasinski
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

8.  A major psychotomimetic complication of multidrug intravenous sedation.

Authors:  J T Jastak; F J Marshall
Journal:  Anesth Prog       Date:  1984 Sep-Oct

9.  Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain.

Authors:  K A Lehmann; B Tenbuhs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.

Authors:  A Cowan; J W Lewis; I R Macfarlane
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.